primitive neuroectodermal tumor cell line tc 71 Search Results


94
ATCC culture pfsk 1
Culture Pfsk 1, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/culture pfsk 1/product/ATCC
Average 94 stars, based on 1 article reviews
culture pfsk 1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

90
Pfizer Inc pnet treatment
Pnet Treatment, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pnet treatment/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
pnet treatment - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

96
ATCC retinoblastoma
Retinoblastoma, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/retinoblastoma/product/ATCC
Average 96 stars, based on 1 article reviews
retinoblastoma - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

90
MBL Life science pnet mbl
Reported toxicities.
Pnet Mbl, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pnet mbl/product/MBL Life science
Average 90 stars, based on 1 article reviews
pnet mbl - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
MBL Life science mbl vpn-9
Reported toxicities.
Mbl Vpn 9, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mbl vpn-9/product/MBL Life science
Average 90 stars, based on 1 article reviews
mbl vpn-9 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
NEN Life Science g3 nen of nf-pnets ≤2
Reported toxicities.
G3 Nen Of Nf Pnets ≤2, supplied by NEN Life Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g3 nen of nf-pnets ≤2/product/NEN Life Science
Average 90 stars, based on 1 article reviews
g3 nen of nf-pnets ≤2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Dohmen GmbH primitive neuroectodermal tumor
Reported toxicities.
Primitive Neuroectodermal Tumor, supplied by Dohmen GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primitive neuroectodermal tumor/product/Dohmen GmbH
Average 90 stars, based on 1 article reviews
primitive neuroectodermal tumor - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
brain products gmbh pnet tcp/ip client
Reported toxicities.
Pnet Tcp/Ip Client, supplied by brain products gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pnet tcp/ip client/product/brain products gmbh
Average 90 stars, based on 1 article reviews
pnet tcp/ip client - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

99
ATCC yes primitive neuroectodermal tumor pnet tp53 homozygous c 823t g p c275g crl 1620tm a172 primary
Reported toxicities.
Yes Primitive Neuroectodermal Tumor Pnet Tp53 Homozygous C 823t G P C275g Crl 1620tm A172 Primary, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/yes primitive neuroectodermal tumor pnet tp53 homozygous c 823t g p c275g crl 1620tm a172 primary/product/ATCC
Average 99 stars, based on 1 article reviews
yes primitive neuroectodermal tumor pnet tp53 homozygous c 823t g p c275g crl 1620tm a172 primary - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

90
STARmed Co Ltd 18 g
EUS-Guided RFA for <t> PNET </t>
18 G, supplied by STARmed Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/18 g/product/STARmed Co Ltd
Average 90 stars, based on 1 article reviews
18 g - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
JCRB Cell Bank human qgp-1 pnet cells
EUS-Guided RFA for <t> PNET </t>
Human Qgp 1 Pnet Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human qgp-1 pnet cells/product/JCRB Cell Bank
Average 90 stars, based on 1 article reviews
human qgp-1 pnet cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Cooperative Human Tissue Network (CHTN cns pnets
Clinical characteristics of <t> CNS </t> PNET ( n =55, including 12 pineoblastomas) and medulloblastoma ( n =62) patient cohorts
Cns Pnets, supplied by Cooperative Human Tissue Network (CHTN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cns pnets/product/Cooperative Human Tissue Network (CHTN
Average 90 stars, based on 1 article reviews
cns pnets - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Reported toxicities.

Journal: Clinical and Translational Radiation Oncology

Article Title: Tomotherapy for cranio-spinal irradiation

doi: 10.1016/j.ctro.2022.11.003

Figure Lengend Snippet: Reported toxicities.

Article Snippet: Bandurska-Luque et al.,2015 , 3 , 3 , Adult , PNET MBL , 25.5–35.3 , 1.6–1.6 , Yes , Nausea Skin Hematologic , – , G3 , – , No treatment interruption.

Techniques:

EUS-Guided RFA for  PNET

Journal: Clinical Endoscopy

Article Title: Therapy of Pancreatic Neuroendocrine Tumors: Fine Needle Intervention including Ethanol and Radiofrequency Ablation

doi: 10.5946/ce.2017.167

Figure Lengend Snippet: EUS-Guided RFA for PNET

Article Snippet: Armellini et al. (2015) [ ] , 1 , PNET , 20 , 18 G, Starmed , - , 1 , Complete , - , None.

Techniques: Functional Assay

Clinical characteristics of  CNS  PNET ( n =55, including 12 pineoblastomas) and medulloblastoma ( n =62) patient cohorts

Journal: British Journal of Cancer

Article Title: An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)

doi: 10.1038/sj.bjc.6604979

Figure Lengend Snippet: Clinical characteristics of CNS PNET ( n =55, including 12 pineoblastomas) and medulloblastoma ( n =62) patient cohorts

Article Snippet: Two CNS PNETs and four pineoblastomas were obtained from CHTN.

Techniques: Biomarker Discovery

Kaplan–Meier curves for analysis of the CNS PNET and medulloblastoma patient cohorts. A significant difference in overall survival was seen between CNS PNET patients under the age of 5 years at diagnosis and those over 5 years ( P =0.045) ( A ). Patients who had a complete rather than partial resection had a better prognosis (overall survival, P =0.01) ( B ). CNS PNET patients treated with both chemotherapy (CT) and radiotherapy (RT) had a significantly better progression-free survival ( P =0.01) ( C ). Medulloblastoma patients under 5 years at diagnosis also showed a significant association with survival (overall survival, P =0.006) ( D ). Medulloblastoma patients that had not relapsed ( P <0.001) ( E ) or metastasised (overall survival, P =0.01) ( F ) had a significantly better prognosis. Medulloblastoma patients treated with either radiotherapy or chemotherapy and radiotherapy also had a better outcome (overall survival, P <0.001) ( G ). All survival times are in months.

Journal: British Journal of Cancer

Article Title: An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)

doi: 10.1038/sj.bjc.6604979

Figure Lengend Snippet: Kaplan–Meier curves for analysis of the CNS PNET and medulloblastoma patient cohorts. A significant difference in overall survival was seen between CNS PNET patients under the age of 5 years at diagnosis and those over 5 years ( P =0.045) ( A ). Patients who had a complete rather than partial resection had a better prognosis (overall survival, P =0.01) ( B ). CNS PNET patients treated with both chemotherapy (CT) and radiotherapy (RT) had a significantly better progression-free survival ( P =0.01) ( C ). Medulloblastoma patients under 5 years at diagnosis also showed a significant association with survival (overall survival, P =0.006) ( D ). Medulloblastoma patients that had not relapsed ( P <0.001) ( E ) or metastasised (overall survival, P =0.01) ( F ) had a significantly better prognosis. Medulloblastoma patients treated with either radiotherapy or chemotherapy and radiotherapy also had a better outcome (overall survival, P <0.001) ( G ). All survival times are in months.

Article Snippet: Two CNS PNETs and four pineoblastomas were obtained from CHTN.

Techniques: Biomarker Discovery

Results for  CNS  PNET and medulloblastoma immunohistochemistry cohorts

Journal: British Journal of Cancer

Article Title: An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)

doi: 10.1038/sj.bjc.6604979

Figure Lengend Snippet: Results for CNS PNET and medulloblastoma immunohistochemistry cohorts

Article Snippet: Two CNS PNETs and four pineoblastomas were obtained from CHTN.

Techniques: Immunohistochemistry, Mutagenesis

Immunohistochemical analysis of CTNNB1, CCND1 and MKI67 in the CNS PNET and medulloblastoma cohorts. Two patterns of CTNNB1 nuclear staining were seen in both CNS PNETs and medulloblastomas. A low level of nuclear staining (less than 10%) was seen in some CNS PNETs ( A ) and medulloblastomas ( B ). In others a high level of nuclear staining (greater than 10%) was seen ( C CNS PNET and D medulloblastoma). Over expression of CCND1 was also seen in a subset of tumours ( E , CNS PNET). MKI67 levels were measured in both cohorts ( F , CNS PNET). Levels did not correlate with CCND1. An additional CNS PNET sample containing a mutation in CTNNB1 exon 3 was analysed in a separate experiment and displayed high CTNNB1 nuclear staining ( G ).

Journal: British Journal of Cancer

Article Title: An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)

doi: 10.1038/sj.bjc.6604979

Figure Lengend Snippet: Immunohistochemical analysis of CTNNB1, CCND1 and MKI67 in the CNS PNET and medulloblastoma cohorts. Two patterns of CTNNB1 nuclear staining were seen in both CNS PNETs and medulloblastomas. A low level of nuclear staining (less than 10%) was seen in some CNS PNETs ( A ) and medulloblastomas ( B ). In others a high level of nuclear staining (greater than 10%) was seen ( C CNS PNET and D medulloblastoma). Over expression of CCND1 was also seen in a subset of tumours ( E , CNS PNET). MKI67 levels were measured in both cohorts ( F , CNS PNET). Levels did not correlate with CCND1. An additional CNS PNET sample containing a mutation in CTNNB1 exon 3 was analysed in a separate experiment and displayed high CTNNB1 nuclear staining ( G ).

Article Snippet: Two CNS PNETs and four pineoblastomas were obtained from CHTN.

Techniques: Immunohistochemical staining, Staining, Over Expression, Mutagenesis

Schematic representation of mutation locations in exon 3 of CTNNB1 . Amino acid substitutions are indicated above the sequence; grey changes represent mutations from medulloblastoma and black from CNS PNET.

Journal: British Journal of Cancer

Article Title: An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)

doi: 10.1038/sj.bjc.6604979

Figure Lengend Snippet: Schematic representation of mutation locations in exon 3 of CTNNB1 . Amino acid substitutions are indicated above the sequence; grey changes represent mutations from medulloblastoma and black from CNS PNET.

Article Snippet: Two CNS PNETs and four pineoblastomas were obtained from CHTN.

Techniques: Mutagenesis, Sequencing

Kaplan–Meier curves for analysis of CTNNB1 IHC. Comparison of CNS PNETs displaying nuclear CTNNB1 with non-nuclear staining did not reveal a significant difference in overall survival ( P =0.852) ( A ). Comparison of high CTNNB1 nuclear tumours (high nuclear) with the rest of the cohort (rest; tumours displaying low nuclear, cytoplasmic or negative staining), although not statistically significant (overall survival, P =0.113), suggested a trend towards a better prognosis for the high CTNNB1 nuclear group ( B ). A significant difference in overall survival was seen between CNS PNETs displaying high and low CTNNB1 nuclear staining (overall survival, P =0.007) ( C ). In the medulloblastoma cohort comparison of nuclear with non-nuclear CTNNB1 tumours was not significant (overall survival, P =0.590), but suggested a trend towards better survival for the nuclear group ( D ). Comparison of CTNNB1 high nuclear cases (high nuclear) with all other tumours in the medulloblastoma cohort (rest) also suggested the same trend (overall survival, P =0.310) ( E ). All survival times are in months.

Journal: British Journal of Cancer

Article Title: An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)

doi: 10.1038/sj.bjc.6604979

Figure Lengend Snippet: Kaplan–Meier curves for analysis of CTNNB1 IHC. Comparison of CNS PNETs displaying nuclear CTNNB1 with non-nuclear staining did not reveal a significant difference in overall survival ( P =0.852) ( A ). Comparison of high CTNNB1 nuclear tumours (high nuclear) with the rest of the cohort (rest; tumours displaying low nuclear, cytoplasmic or negative staining), although not statistically significant (overall survival, P =0.113), suggested a trend towards a better prognosis for the high CTNNB1 nuclear group ( B ). A significant difference in overall survival was seen between CNS PNETs displaying high and low CTNNB1 nuclear staining (overall survival, P =0.007) ( C ). In the medulloblastoma cohort comparison of nuclear with non-nuclear CTNNB1 tumours was not significant (overall survival, P =0.590), but suggested a trend towards better survival for the nuclear group ( D ). Comparison of CTNNB1 high nuclear cases (high nuclear) with all other tumours in the medulloblastoma cohort (rest) also suggested the same trend (overall survival, P =0.310) ( E ). All survival times are in months.

Article Snippet: Two CNS PNETs and four pineoblastomas were obtained from CHTN.

Techniques: Comparison, Staining, Negative Staining